Skip to main content
. 2016 Oct 13;7(43):69225–69230. doi: 10.18632/oncotarget.12648

Table 1. The characteristics of the study population.

AD (n = 984) HC (n = 1352) P value
Age, years; mean±SD 75.15±6.08 75.50±6.49 0.185*
Gender, n (%) 0.074
Male 406 (41.3) 608 (45.0)
Female 578 (58.7) 744 (55.0)
MMSE score, mean±SD 11.99±6.20 28.49±1.09 <0.001
APOE ε4 status, n (%) <0.001
APOE ε4 (+) 280 (28.5) 191 (14.1)
APOE ε4 (-) 704 (71.5) 1161 (85.9)

Abbreviations: AD, Alzheimer's disease; HC, healthy controls; MMSE, Mini-Mental State Examination; ApoE; apolipoprotein E; SD, standard deviation.

*

P value was calculated with the age of onset for late-onset AD and age at examination for control. Differences in the characteristics of age and MMSE score between the two groups were examined using Student's t test. Differences in gender and ApoE-ε4 frequency between AD patients and HC were assessed using the Pearson χ2 test.